Toprak, K. Et Al. 2025. Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction. Angiology , vol.76, no.3 , 302-303.

Toprak, K., KAPLANGÖRAY, M., Inanır, M., Dursun, A., Tascanov, M. B., Altıparmak, I. H., ... Biçer, A.(2025). Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction. Angiology , vol.76, no.3, 302-303.

Toprak, Kenan Et Al. "Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction," Angiology , vol.76, no.3, 302-303, 2025

Toprak, Kenan Et Al. "Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction." Angiology , vol.76, no.3, pp.302-303, 2025

Toprak, K. Et Al. (2025) . "Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction." Angiology , vol.76, no.3, pp.302-303.

@article{article, author={Kenan Toprak Et Al. }, title={Reply to Letter: HbA1c/C-Peptide Ratio is a Potential Biomarker Used to Predict No-Reflow Phenomenon in Patients With ST-Elevation Myocardial Infarction}, journal={Angiology}, year=2025, pages={302-303} }